Ning An Haoyi Wang Hui Zhu Weiwei Yan Wang Jing Li Kong Yan Zhang Jinming Yu
10.2147/OTT.S221638
Onco Targets Ther
2019 Sep 10;12:7399-7404.
egfr rare mutation afatinib epidermal growth factor receptor molecular targeted therapy non-small-cell lung cancer tyrosine kinase inhibitor
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/31686847/
PMC6752199
31686847
Great efficacy of afatinib on a patient with lung adenocarcinoma harboring uncommon EGFR delE709_T710insD mutations: a case report
2019